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broader dose range (double) than the two existing gel 
compositions used for 3D Gel dosimetry applications. Also, 
the novel gel composition showed no apparent change in 
response with post-irradiation time. 
 
   
PD-0383   
A phantom suitable for cell survival investigations using 
flattened and unflattened photon beams 
W. Lechner1, E. Bozsaky1,2, D. Georg1,2, W. Dörr1,2 
1Medizinische Universität Wien Medical University of Vienna, 
Department of Radiation Oncology, Vienna, Austria  
2Christian Doppler Laboratory for Medical Radiation Research 
for Radiation Oncology, Vienna, Austria  
 
Purpose/Objective: Recently, a number of studies 
investigating the difference in cell survival after irradiation 
with unflattened (FFF) compared to flattened beams (FF). 
Most of these studies were, on the one hand, performed 
under 'normal' oxygen conditions (21 %) and, on the other 
hand, dose homogeneity was often established using 
compensators or intensity modulation. The reproducibility of 
such setups has not yet been investigated. The aim of this 
study was to design a phantom capable of establishing 
hypoxic and normoxic conditions, providing a region of 
homogeneous dose distribution using static fields only and 
the possibility to precisely monitor the delivered dose to the 
cells for each experiment. 
Materials and Methods: A VersaHD (Elekta, Crawley, UK) 
linac was utilized, which was commissioned to produce 10 MV 
FF and FFF beams. Doses of 0.5, 1, 2, 4 and 6 Gy were 
delivered to HaCaT (human keratinocytes) cells from a gantry 
angel of 180° using a static 10x10 cm² field. The cells were 
grown and irradiated in chamber slides, which consist of two 
wells each with inner dimensions of 2x2 cm². Only one well 
was used for the cells, the other one was filled with culture 
medium to provide scatter material. A PMMA insert was 
manufactured to fit the chamber slide between solid water 
slabs in a depth of 10 cm. Two holes were drilled through the 
PMMA insert in order to provide gas exchange, either ambient 
air for normoxic or nitrogen for hypoxic conditions. Dose 
homogeneity and monitor units necessary to deliver the 
specified doses to the cells were assessed using EBT3 films. . 
In order to determine the reproducibility of the setup of each 
cell irradiation, a Farmer chamber TM 30006 (PTW, Freiburg, 
Germany) was positioned downstream the beam line. The 
described setup is depicted in Fig. 1a. Cell survival was 
investigated in a clonogenic assay. Based on that, α and β 
values of the cell survival curves were calculated for cells 
irradiated with FF and FFF beams. 
Results: The film measurements showed that when using the 
chamber slides it is possible to establish an isolated region 
with cells where a dose homogeneity within ± 2% can be 
achieved even in FFF mode. The Farmer chamber 
measurements revealed a reproducibility of the dose 
between the individual cell irradiations within 0.5%. Alpha 
values of 0.16 and 0.11 were determined of cells irradiated 
with FF (dose rate ~4 Gy/min) and FFF beams (dose rate ~16 
Gy/min), respectively. Both values agreed within their 
uncertainty. Beta values were 0.05 for both FF and FFF 
beams. 
 
Conclusions: An experimental setup could be established for 
reproducible cell irradiations in FF and FFF mode with 
sufficient dose homogeneity, without altering the beam itself 
or by the use of compensators or intensity modulation. 
Furthermore, this experimental setup enables simulation of 
different oxygen conditions. So far, no difference in survival 
of HaCaT cells was detected between irradiation with FFF or 
FF beams.  
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Purpose/Objective: With the aim of improving the accuracy 
and consistency of clinical dosimetry in hospitals world-wide, 
the XX Thermoluminescence Dosimetry (TLD) Postal Audit 
Program has been operating since 1969. In this study, we 
explore the dependence of the quality of clinical dosimetry in 
participating institutions on several key infrastructure 
characteristics. 
Materials and Methods: The Postal Audit Program compares 
the dose read from the mailed TLD with that stated to have 
been delivered by the Institution. Agreement to within ±5% is 
regarded as being acceptable with larger deviations 
triggering follow-up actions. Of particular interest in this 
study was the dependence of clinical dosimetry quality on i) 
age of the treatment machine, ii) 60Co vs linac, iii) number of 
machines in the participating centre, iv) elapsed time since 
the last dosimetry system calibration v) whether the audit 
was the first one or a subsequent one and vi) the dosimetry 
protocol used (a sub-set of 7182 TLDs). Quality, in this 
context, is defined as the percentage of results within the 
XX's criterion of acceptability of ±5%. Also, it is to be noted 
that the term 'clinical dosimetry' encompasses calibration of 
the institution's beam, the institution's dosimetry calculations 
and irradiation of the Postal Audit TLDs as it was clearly not 
possible to isolate these different contributors to the final 
result. 
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Results: Whereas for machines younger than 10 years 
agreement between measured and stated dose was 90% 
overall, for those over 30 years old agreement dropped to 
70%. However, this picture varied with region. Linac 
dosimetry was always better than 60Co and multi-machine 
centres generally performed better than single machine 
institutions. We interpret this latter observation as a 
reflection of a more substantial physics infrastructure in 
larger centres. The data suggest virtually no dependence on 
the time elapsed since the last dosimetry system calibration 
at least out to 10 years. Second or subsequent participation 
in audits reflected higher quality dosimetry (85% of results 
within the XX's acceptance criterion) than the first audit 
(77%). The use of ND,w based dosimetry protocols resulted in 
more accurate dosimetry than the use of the older Nk or Nx 
protocols (95%, 92% and 79% agreement respectively). 
Conclusions: Clearly, over the 45 years that the XX has 
accumulated these TLD data, practice has changed both in 
institutions and at the XX's Dosimetry Laboratory. However, it 
is possible to draw some general conclusions from the 
analysis. Higher quality dosimetry is generally associated with 
younger machines, linacs as opposed to 60Co, centres with 
more than one machine, prior experience with the XX's audit 
programme and the use of an ND,w based protocol.  
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Purpose/Objective: To evaluate the dosimetric properties of 
the synthetic diamond dosimeter PTW 60019 (microDiamond) 
in high-energy scanned clinical carbon ion beams.  
Materials and Methods: The measurements were performed 
at the National Center for Oncological Treatment (CNAO) 
synchrotron facility. The detector response was tested under 
actively scanned carbon ion beams ranging from 115 to 380 
MeV/u. All measurements were performed in a water 
phantom. The detector performance was firstly evaluated in 
terms of response stability, dependence on beam energy and 
ion type (carbon ions and protons), linearity with dose, dose 
rate and angular dependence. The depth dose curve of a 280 
MeV/u carbon ion beam, obtained by the microDiamond 
detector was compared to the one measured using a PTW 
Advanced Markus ionization chamber, and to numerical 
simulation from FLUKA Monte Carlo code. Dose 
measurements in spread-out-Bragg-peaks (SOBP) were also 
performed and the results were compared to the data from 
the treatment planning system (TPS). 
Results: A response reproducibility within about 1% was 
found. Deviations of the calibaration factor below 3.5% with 
respect to the reference Co-60 source were observed for the 
whole set of beam qualities investigated (including protons). 
The detector response showed a good linear behavior and its 
sensitivity was found to be dose rate independent, with a 
variation below 1.3% in the evaluated dose rate range. Very 
good agreement between the measured Bragg peak curves, 
with respect both to the ones obtained by the Advanced 
Markus chamber and to simulated ones were observed, 
demonstrating a substantial LET independence of the 
microDiamond response. Very good results were also obtained 
from SOBP measurements, with a difference below 1% 
between measured and TPS-calculated doses.  
Conclusions: The results of the present study showed that 
the microDiamond detector is suitable for clinical carbon ion 
beams dosimetry.  
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Purpose/Objective: Flattening filter free (FFF) beams are 
becoming the new gold standard modality for clinical 
stereotactic body radiotherapy (SBRT). Beneficial 
characteristics compared to conventional flattened fields 
(FF) include higher dose rate, reduced lateral changes in 
beam hardening, reduced leakage, and less out-of-field dose 
and these have the potential to improve treatment plans. 
The two main accelerator manufacturers have chosen to 
implement FFF with different energy definitions and are 
using quite different MLC designs, which might also influence 
the achievable plan quality, as might the use of different 
treatment planning systems (TPS) with different MLC 
segmentation algorithms. This study investigates the 
possibility of creating FFF plans with high dose delivery 
accuracy across the different vendors, energies, and TPSs 
used for planning. 
Materials and Methods: Ten lung patient cases were 
provided to seven different cancer treatment centres for 
SBRT planning using FF and FFF beams. The different centres’ 
linac/TPS combinations were: Varian-Eclipse, Varian-
Pinnacle, Novalis-Eclipse, Elekta-Pinnacle and Elekta-Monaco. 
All planning followed the same protocol. The prescribed 
minimum dose was 48Gy/4fr for tumours located less than 
1.5cm from the thorax wall, 50Gy/5fr for tumours located 
within 2cm of the main bronchial tree, and 54Gy/3fr for free 
lying tumours in the lung. Half circle VMAT arcs were used for 
all plans avoiding the contra lateral lung. All treatment plans 
were delivered and measured using the Sun Nuclear ArcCheck 
phantom and evaluated using a 3% and 3 mm gamma analysis 
between planned and measured doses. Beam on times were 
recorded for the treatment beams. All DVH metrics were 
tested for significant differences with a paired two-sided 
Wilcoxon-signed rank test, with a significance level of 5%. 
Results: All the linac-TPS combinations show high dose 
accuracy across the ten patients, with a mean pass rate of 
98.1% and 97.4% for FF and FFF treatment plan respectively 
(see table). For the Elekta-Pinnacle combination the FFF 
plans have lower pass rates than FF plans, which might be 
related to the relative calibration of the ArcCheck phantom 
